Drugs / FRD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03366493 | Dec 2017 → Dec 2018 | cervical intraepithelial neoplasia grade 2/3 | GY Highland Biotech LLC | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FRD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03366493 ↗ |
| Modality | Diagnostic / imaging agent | “The Folate Receptor-Mediated Staining Solution is a dye solution that stains for medical purposes used in staining cells and tissues for detecting neoplastic diseases.” NCT03366493 ↗ |
| Route | Other | “the FRD™ staining solution will be applied to the cervix using an applicator.” NCT03366493 ↗ |